Biological technologies office studies - pharaoh: sequence specific DNA methylation to modulate gene expression
Ended Definitive Contract Awarded Last action
- Contract number
- HR001116C0065
- Awardee
-
Ibis Biosciences, Inc. UEI RJFAJH9C77R3
- Awarding agency
-
Defense Contract Management Agency
Department of Defense
- Obligated
- $2,102,002
Award facts
- Opportunity
-
- HR001116R0065 Solicitation number
- PHARAOH: Sequence Specific DNA Methylation to Modulate Gene Expression Award Notice · Posted Feb 26, 2016
- Contract value 100% obligated
- $2,102,002.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Funding agency
- Defense Advanced Research Projects Agency Department of Defense
- NAICS code
- 541711 Research and Development in Biotechnology
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 60 offers Basic Research
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Carlsbad, CA 92008, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Other Administrative Action | $0 | |
| Original award | $2,102,002 |
Show all 11
About this award
This is a $2,102,002.00 cost-plus-fixed-fee definitive contract awarded by the Defense Advanced Research Projects Agency (DARPA) to Ibis Biosciences, Inc. for "BIOLOGICAL TECHNOLOGIES OFFICE STUDIES - PHARAOH: SEQUENCE SPECIFIC DNA METHYLATION TO MODULATE GENE EXPRESSION." The contract has an ultimate completion date of September 30, 2017 and was awarded on February 1, 2016. There was no set-aside used for this contract. As this is a DARPA contract, it is likely focused on advanced biological research and technology development to support national defense priorities.
Quick answers
Who was awarded contract HR001116C0065?
HR001116C0065 was awarded to Ibis Biosciences, Inc. by Defense Contract Management Agency (Department of Defense) on February 1, 2016.
How much is contract HR001116C0065 worth?
The government has obligated $2,102,002 on HR001116C0065.
Which agency awarded contract HR001116C0065?
Defense Contract Management Agency (Department of Defense) awarded HR001116C0065, with funding from Defense Advanced Research Projects Agency (Department of Defense).
Was contract HR001116C0065 competed?
The extent of competition for HR001116C0065 was full and open competition. The government received 60 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award